Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer: Complete Statistical AnalysisIndependent statistical analysis of PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- PMCF Study on PEEK Suture Anchors for Shoulder Indications: Complete Statistical AnalysisIndependent statistical analysis of PMCF Study on PEEK Suture Anchors for Shoulder Indications: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03826667).
- PMNCIndependent statistical analysis of Evaluation of the Spectra Optia PMN Cell Collection Procedure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01805180).
- PMS-001Independent statistical analysis of An Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05025241).
- PNCAIndependent statistical analysis of Parent/Nurse Controlled Analgesia in the Neonatal Intensive Care Unit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01823497).
- PNEU-WAY PEDIndependent statistical analysis of Safety and Immunogenicity of V114 in Children Infected With Human Immunodeficiency Virus (HIV) (V114-030/PNEU-WAY PED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines: Complete Statistical AnalysisIndependent statistical analysis of Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- PNPIndependent statistical analysis of Purge Vs no Purge in Living Donor Liver Transplantation Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02540447).
- POC1Independent statistical analysis of Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- POCDIndependent statistical analysis of Post-Operative Cognitive Dysfunction in Normal Aging Patients Undergoing Elective Orthopedic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- POCHARBIIndependent statistical analysis of Impact of Chemotherapy Followed by Aromatase Inhibitors on Bone Health of Women With ER-positive Early Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Pocket Echocardiography System (PES) for Detection of PDA in Neonates: Complete Statistical AnalysisIndependent statistical analysis of Pocket Echocardiography System (PES) for Detection of PDA in Neonates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01790750).
- POCPREGIndependent statistical analysis of Efficacy Evaluation of Using Finger Stick Peripheral Blood for Point of Care Pregnancy Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- POEMIndependent statistical analysis of POEM (Practice Of Embracing Each Moment) STUDY: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03078608).
- POINTIndependent statistical analysis of Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Point-of-care Management of Coagulopathy in Lung Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Point-of-care Management of Coagulopathy in Lung Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03598907).
- POINTSIndependent statistical analysis of The Personalized Nutrition Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04145466).
- POLAR SMARTIndependent statistical analysis of POLARx™ Cardiac Cryoablation System Post Market Clinical Study (POLAR SMART): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05282823).
- Polar Wand Carbon Dioxide Cryotherapy for Barrett’s Esophagus: Complete Statistical AnalysisIndependent statistical analysis of Polar Wand Carbon Dioxide Cryotherapy for Barrett's Esophagus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01477177).
- POLAR-AIndependent statistical analysis of Preventive Treatment of OxaLiplatin Induced peripherAl neuRopathy in Adjuvant Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PolenIndependent statistical analysis of Preoperative Olaparib Endometrial Carcinoma Study (POLEN): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02506816).
- Pollen+Independent statistical analysis of Grass Pollen Allergen Immunotherapy Tablet (AIT) Time Course Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02005627).
- POLY-ACSIndependent statistical analysis of Polypill in Acute Coronary Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05514938).
- POLYP 2Independent statistical analysis of A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep Disturbance: Complete Statistical AnalysisIndependent statistical analysis of Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep Disturbance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT.: Complete Statistical AnalysisIndependent statistical analysis of Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT.: primary endpoint results, effect estimate with confidence…
- Ponatinib for Squamous Cell Lung and Head and Neck Cancers: Complete Statistical AnalysisIndependent statistical analysis of Ponatinib for Squamous Cell Lung and Head and Neck Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01761747).
- POPIndependent statistical analysis of Toradol v. Celecoxib for Postoperative Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03331315).
- POP-ACLRIndependent statistical analysis of The PreOperative Management of Patients Awaiting Anterior Cruciate Ligament Reconstruction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05529511).
- POPPiIndependent statistical analysis of Improving Uptake and Adherence to HIV Prevention Services With Pre-exposure Prophylaxis (PrEP), HIV Self- Testing and Adherence Support for Very High Risk HIV-negative Young Women Aged 15-24 in…
- PoPPSIndependent statistical analysis of Prevention of Preterm Birth With a Pessary in Singleton Gestations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02056652).
- PopSole2Independent statistical analysis of Validation of a Novel Foot Offloading Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04378270).
- Porfimer Sodium Interstitial Photodynamic Therapy With or Without Standard of Care Chemotherapy in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Porfimer Sodium Interstitial Photodynamic Therapy With or Without Standard of Care Chemotherapy in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer: primary endpoint results, effect…
- PORTICO-1Independent statistical analysis of 5 Year Observation of Patients With PORTICO Valves: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01802788).
- Portion Control Treatment for Obesity: Complete Statistical AnalysisIndependent statistical analysis of Portion Control Treatment for Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01451554).
- POSAIndependent statistical analysis of Single Dose Population Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients: Complete Statistical AnalysisIndependent statistical analysis of Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03318159).
- Positive Youth Development in the Metaverse: Complete Statistical AnalysisIndependent statistical analysis of Positive Youth Development in the Metaverse: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05858593).
- Post Approval Study of the AcrySof® IQ ReSTOR® Toric IOLs: Complete Statistical AnalysisIndependent statistical analysis of Post Approval Study of the AcrySof® IQ ReSTOR® Toric IOLs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03733730).
- Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data: Complete Statistical AnalysisIndependent statistical analysis of Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Post Market Study Using the Xoft Axxent System: Complete Statistical AnalysisIndependent statistical analysis of Post Market Study Using the Xoft Axxent System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01017549).
- Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO): Complete Statistical AnalysisIndependent statistical analysis of Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Post Marketing Surveillance (PMS) of JARDIANCE in Chronic Heart Failure (CHF): Complete Statistical AnalysisIndependent statistical analysis of Post Marketing Surveillance (PMS) of JARDIANCE in Chronic Heart Failure (CHF): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Post Marketing Surveillance For General Drug Use To Assess the Safety And Efficacy Profile Of Viviant In Usual Practice: Complete Statistical AnalysisIndependent statistical analysis of Post Marketing Surveillance For General Drug Use To Assess the Safety And Efficacy Profile Of Viviant In Usual Practice: primary endpoint results, effect estimate with confidence interval, sample-size…
- Post Marketing Surveillance To Observe Safety And Efficacy Of Duavive: Complete Statistical AnalysisIndependent statistical analysis of Post Marketing Surveillance To Observe Safety And Efficacy Of Duavive: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02792504).
- Post Operative Sore Throat and Dexamethasone: Complete Statistical AnalysisIndependent statistical analysis of Post Operative Sore Throat and Dexamethasone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01052038).
- Post Transplant Donor Lymphocyte Infusion: Complete Statistical AnalysisIndependent statistical analysis of Post Transplant Donor Lymphocyte Infusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00167180).
- Post Treatment Comparison Intramedullary Nail vs. Nonoperative Treatment: Complete Statistical AnalysisIndependent statistical analysis of Post Treatment Comparison Intramedullary Nail vs. Nonoperative Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01975467).
- Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England: Complete Statistical AnalysisIndependent statistical analysis of Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric PIDD Subjects: Complete Statistical AnalysisIndependent statistical analysis of Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric PIDD Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…